Accelerate your research from strategy to completion with a partner equipped with robust experience, knowledge and expertise in the cardiology market.
We have supported trials across a range of cardiovascular diseases, allowing us to deliver exceptional personalized experiences.
Despite committed and sustained efforts in clinical research, cardiovascular disease (CVD) remains the number one health threat worldwide, with the majority of deaths from CVD occurring in developed geographies like North America, Europe and Asia.
We have extensive experience in cardiovascular clinical trials and research, including therapies such as stem cells and inhibitors. Our experts share their knowledge to help devise strategies and support the delivery of your cardiovascular studies for drug/device and cardiac safety as well as large cardiovascular endpoint trials that demand rigorous safety requirements while seamlessly integrating with metabolic/endocrinology projects where needed.
Based on our experience and understanding of the therapeutic space, we connect you with hospitals and outpatient settings to help you accelerate trial start-up and get the results you need, optimizing the identification, recruitment and retention of the right patients and sites for your clinical studies.
Our dedicated team coordinates all aspects of your program with innovative monitoring, constant analysis and shared insight to deliver the highest quality data you need to advance your therapy.
Every individual working with you takes responsibility for the success of your project to deliver the best possible outcomes. Our team removes barriers and expedites critical decisions to help you reach your critical milestones quicker.
We are fully invested in the outcomes of your trials, providing the resources and expertise when and how you need them and sharing therapeutic area expertise and knowledge to help you make the best decisions.
Ready for the next step in your drug development journey? Learn more about how our personalized solutions can help you enable better healthcare outcomes.
Explore our news and updates as we liberate the clinical research process.
News
07/22/2024
News
06/12/2024